Elif Ozbay's Contact Details

Elif Ozbay's Company Details

Medipol SABİTA

İstanbul, İstanbul, Turkey • 37 Employees
Research

The scientific world has come to an understanding that the design and conduct of biomedical research should aim translation of findings from bench to bedside. Almost all medicine disorders involve loss or dysfunction of cells, tissues or organs. As humans, we have the capacity to replenish the lost, but only to a limited extend. On the other hand, there are more successful examples of tissue regeneration in other living beings in nature. Hints from these organisms and ever-expanding knowledge on stem cells, growth factors and extracellular matrix encourage us to develop strategies to regenerate lost body parts and restore their functions. Engineering has made tremendous progress in recent years and contributed to medicine more than ever. From fabrication of biomaterials to the construction of robotic prostheses regenerative and restorative strategies heavily depend on and boosted by new technology.At Medipol, as we shaped the research vision of our young university we chose the regenerative medicine as a strategic field for research. Within a couple of years we achieved establishment of the core units of a thematic research center, which was supported by a government grant from The Ministry of Development. Medipol Regenerative and Restorative Medicine Research Center (REMER) is organized to harbor multiple core facilities and labs with the highest technology available and has already started to attract many high profile researchers from all over the world. We have a vision to cover all main areas of the regenerative medicine by encouraging formation of several topic-specific research groups led by prominent scientists.